Richard Rodgers compensation by year
Opus Genetics Summary Compensation Table · the one fiscal year held| Component | FY2023 |
|---|---|
| Salary | $379,626 |
| Bonus | $100,000 |
| Stock awards | $419,450 |
| Option awards | $0 |
| Non-equity incentive | $0 |
| Pension and deferred compensation | $0 |
| All other | $0 |
| Total | $899,076 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Opus Genetics, Inc. DEF 14A filed April 29, 2024, accession 0001140361-24-023004, and prior-year filings. Open the filing on EDGAR.
How this page was built: the Opus Genetics, Inc. filed document, accession 0001140361-24-023004. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2024.
Equity holdings
unvested awards at FY2023 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 50,000 | $150,500 | — |
| RSU | 35,000 | $105,350 | — |
Per the Outstanding Equity Awards at Fiscal Year-End table in Opus Genetics, Inc.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.
Opus Genetics’s named executive officers, FY2023
as the company reported each| Named executive officer | Role | FY2023 total |
|---|---|---|
| Mina Sooch | Former Chief Executive Officer and President | $2,811,138 |
| George Magrath | Chief Executive Officer | $2,667,353 |
| Ronil Patel | Chief Business Officer | $1,102,364 |
| Richard Rodgers · this page | Director and Former Interim Chief Executive Officer and President | $899,076 |
| Bernhard Hoffmann | Senior Vice President of Corporate Development | $789,918 |
| Amy Rabourn | Senior Vice President of Finance | $789,918 |
Board service
Opus Genetics board · FY2021–FY2025| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $63,813 | $75,529 | $50,108 | $0 | $189,450 |
| FY2024 | $144,500 | $75,800 | $47,177 | $0 | $267,477 |
| FY2022 | $62,000 | — | $29,530 | — | $91,530 |
| FY2021 | $60,000 | — | $87,301 | — | $147,301 |
Each year as the company reported it in Opus Genetics's director compensation table. Totals are the company's own disclosed totals.
How this board is paid
Company policy: Opus Genetics pays directors a $42,000 cash retainer and $120,000 in RSUs and Options. As stated in Opus Genetics's FY2025 proxy.
Committees
Audit (Chair)
The full Opus Genetics compensation record
free company briefThis page is one person within Opus Genetics's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the Opus Genetics proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Opus Genetics's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.